CM
BIIB icon

Columbus Macro’s Biogen BIIB Stock Holding History

Columbus Macro’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,520
Closed -$354K – 174
2019
Q3 		$354K Sell
1,520
-282
-16% -$65.7K 0.09% 120
2019
Q2 		$421K Buy
1,802
+52
+3% +$12K 0.09% 118
2019
Q1 		$414K Sell
1,750
-47
-3% -$14.8K 0.09% 116
2018
Q4 		$541K Sell
1,797
-81
-4% -$25.9K 0.12% 101
2018
Q3 		$664K Buy
1,878
+55
+3% +$18.9K 0.16% 86
2018
Q2 		$529K Sell
1,823
-50
-3% -$14.1K 0.14% 95
2018
Q1 		$513K Buy
+1,873
New +$581K 0.13% 88

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Columbus Macro's BIIB Position: Q4 2019 in Review

Columbus Macro sold out of Biogen (BIIB) in Q4 2019, closing a stake of 1,520 shares — an estimated $354K sold.

Columbus Macro first reported a position in BIIB in Q1 2018 and held it in 7 quarters. The position peaked at $664K in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Columbus Macro reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Columbus Macro sold 1,520 Biogen shares in Q4 2019, an estimated $354K.
  • Columbus Macro first reported a position in Biogen in Q1 2018 and held it in 7 quarters.
  • Columbus Macro's Biogen position peaked at $664K in Q3 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Columbus Macro's 13F filing for Q4 2019, filed 27 Jan 2020.